Tea Glonti

Publikationen pro Jahr

Fingerprint

Ergründen Sie die Forschungsthemen, in denen Tea Glonti aktiv ist. Diese Themenbezeichnungen stammen aus den Werken dieser Person. Zusammen bilden sie einen einzigartigen Fingerprint.

1 Ähnliche Profile

1 Abgeschlossen
1 Laufend

HFM/21-10: SynPhage (Synthetic Phage)
Pirnay, J.-P. (Leitende(r) Forscher/-in) & Glonti, T. (Forschende)
1/01/21 → 31/12/24
Projekt: Forschung › Research
INTELIPHAGES: Inteliphages: a powerful therapy to fight antimicrobial resistance
Pirnay, J.-P. (Leitende(r) Forscher/-in), Cochez, C. (Forschende) & Glonti, T. (Forschende)
1/07/19 → 31/12/23
Projekt: Forschung › Research

6 Artikel
2 Übersichtsartikel

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study
Pirnay, J. P., Djebara, S., Steurs, G., Griselain, J., Cochez, C., De Soir, S., Glonti, T., Spiessens, A., Vanden Berghe, E., Green, S., Wagemans, J., Lood, C., Schrevens, E., Chanishvili, N., Kutateladze, M., de Jode, M., Ceyssens, P. J., Draye, J. P., Verbeken, G. & De Vos, D. &81 mehr, Rose, T., Onsea, J., Van Nieuwenhuyse, B., Soentjens, P., Lavigne, R., Merabishvili, M., Pang, K. W., Metsemakers, W. J., Van der Linden, D., Chatzis, O., Eskenazi, A., Lopez, A., De Voeght, A., Rousseau, A. F., Tilmanne, A., Vens, D., Gérain, J., Layeux, B., Vlieghe, E., Baar, I., Van Ierssel, S., Van Laethem, J., Guiot, J., De Roock, S., Jennes, S., Uyttebroek, S., Van Gerven, L., Hellings, P. W., Dupont, L., Debaveye, Y., Devolder, D., Spriet, I., De Munter, P., Depypere, M., Vanfleteren, M., Cornu, O., Verhulst, S., Boiy, T., Lamote, S., Van Zele, T., Wieërs, G., Courtin, C., Lebeaux, D., Sartre, J., Ferry, T., Laurent, F., Paul, K., Di Luca, M., Gottschlich, S., Tkhilaishvili, T., Cesta, N., Racenis, K., Barbosa, T., López-Cortés, L. E., Tomás, M., Hübner, M., Pham, T. T., Nagtegaal, P., Ten Oever, J., Daniels, J., Loubert, M., Iheb, G., Jones, J., Hall, L., Young, M., Balarjishvili, N., Tediashvili, M., Tong, Y., Rohde, C., Wittmann, J., Hazan, R., Nir-Paz, R., Azeredo, J., Krylov, V., Cameron, D., Pitton, M., Que, Y. A., Resch, G., McCallin, S., Dunne, M. & Kilcher, S., Juni 2024, in: Nature Microbiology. 9, 6, S. 1434-1453 20 S.
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Open Access
Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails
Glonti, T., Goossens, M., Cochez, C., Green, S., Gorivale, S., Wagemans, J., Lavigne, R. & Pirnay, J. P., Mai 2024, in: Antibiotics. 13, 5, 385.
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Open Access
Eudragit^® FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration
Tabare, E., Dauchot, T., Cochez, C., Glonti, T., Antoine, C., Laforêt, F., Pirnay, J. P., Delcenserie, V., Thiry, D. & Goole, J., Juni 2023, in: Pharmaceutics. 15, 6, 1602.
Publikation: Beitrag in Fachzeitschrift › Artikel › Begutachtung

Open Access
Determination of phage susceptibility as a clinical diagnostic tool: A routine perspective
Daubie, V., Chalhoub, H., Blasdel, B., Dahma, H., Merabishvili, M., Glonti, T., De Vos, N., Quintens, J., Pirnay, J. P., Hallin, M. & Vandenberg, O., 21 Sept. 2022, in: Frontiers in Cellular and Infection Microbiology. 12, 1000721.
Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

Open Access
In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success
Glonti, T. & Pirnay, J. P., Juli 2022, in: Viruses. 14, 7, 1490.
Publikation: Beitrag in Fachzeitschrift › Übersichtsartikel › Begutachtung

Open Access

Tea Glonti

Fingerprint

Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre

Details ergründen

HFM/21-10: SynPhage (Synthetic Phage)

INTELIPHAGES: Inteliphages: a powerful therapy to fight antimicrobial resistance

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails

Eudragit^® FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration

Determination of phage susceptibility as a clinical diagnostic tool: A routine perspective

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success

Tea Glonti

Fingerprint

Kooperationen und Spitzenforschungsbereiche der letzten fünf Jahre

Projekte

HFM/21-10: SynPhage (Synthetic Phage)

INTELIPHAGES: Inteliphages: a powerful therapy to fight antimicrobial resistance

Publikationen

Personalized bacteriophage therapy outcomes for 100 consecutive cases: a multicentre, multinational, retrospective observational study

Use of the Naturally Occurring Bacteriophage Grouping Model for the Design of Potent Therapeutic Cocktails

Eudragit® FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration

Determination of phage susceptibility as a clinical diagnostic tool: A routine perspective

In Vitro Techniques and Measurements of Phage Characteristics That Are Important for Phage Therapy Success

Eudragit^® FS Microparticles Containing Bacteriophages, Prepared by Spray-Drying for Oral Administration